

The Two Sides of Gene Editing with Kevin Davies
Aug 21, 2024
Kevin Davies, executive editor of The CRISPR Journal and author of 'Editing Humanity', discusses the cutting-edge advancements in gene editing, particularly CRISPR's transformative role in treating diseases like sickle cell. He Jiankui's controversial gene editing work raises questions about ethics and oversight in the field. The conversation also emphasizes the balance between innovation and moral responsibility, highlighting accessibility issues and the potential for wealth disparities in accessing gene editing technologies.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 3min
CRISPR: Revolutionizing Genetic Medicine
02:44 • 12min
Reflections on CRISPR, Education, and Cloud Innovation
14:24 • 2min
Ethics and Innovation in CRISPR Technology
16:50 • 31min
Moral Dilemmas in Gene Editing
48:18 • 4min
Exploring Accessibility and Ethical Dilemmas in Gene Editing
52:30 • 3min